AbbVie
ABBV
#30
Rank
C$414.71 B
Marketcap
$234.68
Share price
-1.82%
Change (1 day)
24.08%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : C$193.53 Billion

According to AbbVie's latest financial reports the company's total liabilities are C$193.53 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

AbbVie - Total liabilities on balance sheet (from 2011 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31C$164.88 B-0.01%
2022-12-31C$164.89 B-1.3%
2021-12-31C$167.07 B-4.68%
2020-12-31C$175.28 B37.95%
2019-12-31C$127.06 B37.58%
2018-12-31C$92.35 B11.83%
2017-12-31C$82.58 B-0.01%
2016-12-31C$82.59 B21.26%
2015-12-31C$68.11 B127.77%
2014-12-31C$29.90 B13.72%
2013-12-31C$26.29 B11.85%
2012-12-31C$23.51 B204.59%
2011-12-31C$7.71 B42.18%
2010-12-31C$5.42 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
C$178.83 B-7.60%๐Ÿ‡บ๐Ÿ‡ธ USA
C$107.75 B-44.33%๐Ÿ‡บ๐Ÿ‡ธ USA
C$86.35 B-55.38%๐Ÿ‡บ๐Ÿ‡ธ USA
C$117.45 B-39.31%๐Ÿ‡บ๐Ÿ‡ธ USA
C$49.85 B-74.24%๐Ÿ‡บ๐Ÿ‡ธ USA
C$16.84 B-91.30%๐Ÿ‡บ๐Ÿ‡ธ USA
C$84.09 B-56.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
C$91.22 B-52.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
C$1.14 B-99.41%๐Ÿ‡บ๐Ÿ‡ธ USA